Palantir Technologies Inc. and Deloitte have launched a strategic alliance targeting enterprise artificial intelligence transformation.

Additional results include a 30% improvement in MRI imaging turnaround time, an 83% reduction in patient placement time and a 28% decrease in post-anesthesia care unit holds, among other successes.

Palantir's expanding government partnerships, AI-driven innovation, and strong financial growth make it a compelling buy. Learn more about PLTR stock here.

Palantir's Artificial Intelligence Platform (AIP) is emerging as its breakout commercial product. Launched as the fourth ...

Palantir Technologies' advanced data mapping and AI solutions give it a strong moat and impressive profitability. Click here ...

Once again, Palantir Technologies ( PLTR -1.14%) is easily outpacing the S&P 500 this year. As of mid-2025, the stock has ...